Retatrutide 20mg

Retatrutide is a triple glucose-dependent insulinotropic peptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptor agonist. This third generation peptide works by activating multiple metabolic pathways to support weight management and metabolic health.

The GLP-1 receptor (Glucagon-Like Peptide-1) enhances insulin secretion in response to glucose, improves beta cell function, and promotes satiety signaling in the brain. The GIP receptor (Glucose-dependent Insulinotropic Polypeptide) works synergistically to further stimulate insulin release in a glucose-dependent manner while modulating appetite regulation. The glucagon agonist receptor agonist binds to glucagon receptors in the body to mimic the hormone glucagon, which breaks down stored fats, and increases energy use. Together, these triple mechanisms supports improved glycemic control and may help reduce appetite and food cravings.

Retatrutide represents a next-generation approach to metabolic support, combining the benefits of three receptor pathways in a single peptide. Users may experience improved body composition, enhanced metabolic rate, and better overall metabolic function.

This 20mg formulation is designed for research and personal use applications. Always consult with a healthcare provider before use, and ensure compliance with all local regulations regarding peptide products.